Not Just Healthcare... Lifecare.

Business Areas


India

Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.

International

With significant presence in more than 50 countries, Torrent is all poised to spread wings across globe with strong technical capabilities and international accreditations. To enable strategic differentiation, Torrent Pharma’s international business is segregated into US, UK, Germany, Europe, Brazil and Rest of the World.


Products


image

Therapeutic Areas

Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
image

Prescribing Information

Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
image

Report Adverse Event /
दवाओं का दुष्प्रभाव रिपोर्टिंग

Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.


Quick Facts


8

Manufacturing Plants

750 +

Scientists

2000 +

Product Registrations

Presence in 50 +

Countries


News & Events


Quarterly Results

May 24, 2024Mumbai(India)

Torrent Pharma announces Q4 FY24 Results click here

TPL NLEM Price Revision

May, 16 2024Ahmedabad

Torrent Pharmaceuticals Ltd has reduced the MRP of NLEM product click here

Quarterly Results

February 02, 2024Ahmedabad(India)

Torrent Pharma announces Q3 FY24 Results click here

Agreement

November 10, 2023Ahmedabad(India)

Torrent and Zydus sign licensing agreement click here

Quarterly Results

October 23, 2023Ahmedabad(India)

Torrent Pharma announces Q2 FY24 Results click here

EIR from US FDA for Dahej facility

August 24th, 2023Ahmedabad(India)

Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility click here

Quarterly Results

August 7th, 2023Ahmedabad(India)

Torrent Pharma announces Q1 FY24 results click here

NLEM Price Revision

Jun, 30 2023Ahmedabad

Torrent Pharmaceuticals Ltd has reduced the MRP of NLEM product click here

Quarterly Results

May 30, 2023 Mumbai, Maharashtra.

Torrent Pharma announces Q4 FY23 results click here

NLEM Price Revision

April, 18 2023Ahmedabad, India

Torrent Pharmaceuticals Ltd. has reduced the MRP of NLEM Products click here

NLEM Price Revision

April, 18 2023 Ahmedabad

Curatio Healthcare (I) Pvt Ltd. (A Torrent Pharmaceuticals Ltd Subsidiary ) has reduced the MRP of NLEM product click here

NLEM Price Revision

March 10, 2023Ahmedabad India

Torrent Pharmaceutical Ltd. has reduced the MRP of NLEM Products click here

Quarterly Results

January 25, 2023Ahmedabad India

Torrent Pharma announces Q3 FY23 results click here

Agreement

December 14, 2022Ahmedabad India

Torrent Pharmaceuticals Ltd enters into co-marketing partnership click here

Quarterly Results

October 21, 2022Ahmedabad (India)

Torrent Pharma announces Q2 FY23 Results click here

Acquisition

September 27, 2022Ahmedabad (India)

Torrent Pharma to acquire Curatio Healthcare click here

Quarterly Results

July 29, 2022Ahmedabad (India)

Torrent Pharma announces Q1 FY23 results click here

Agreement

May 26, 2022Ahmedabad (India)

Torrent Pharma acquires 4 Brands from Dr.Reddy’s laboratories click here

Quarterly Results

May 25, 2022Ahmedabad (India)

Torrent Pharma announces Q4 FY22 results click here

Agreement

March 17, 2022Ahmedabad (India)

Torrent Pharma enters into licensing agreement with Medicine Patent Pool to manufacture and commercialise generic version of Pfizer Oral COVID-19 Treatment click here

Quarterly Results

January 25th, 2022 Ahmedabad (India)

Torrent Pharma announces Q3 FY22 results click here

Product Launch

December 28th, 2021Ahmedabad (India)

Torrent Pharma to launch Molnupiravir under the brand name Molnutor® in India click here

Quarterly Results

October 26th, 2021Ahmedabad (India)

Torrent Pharma announces Q2 FY22 results click here

Quarterly Results

July 27th, 2021Ahmedabad (India)

Torrent Pharma announces Q1 FY22 results click here

Agreement

June 29th, 2021India

Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19 click here

Quarterly Results

May 18th, 2021Ahmedabad(India)

Torrent Pharma announces Q4 FY21 results click here

Agreement

May 13th, 2021Ahmedabad(India)

Torrent Pharma Enters Into Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19 in India click here

Quarterly Results

February 8th, 2021Ahmedabad(India)

Torrent Pharma announces Q3 FY21 results click here

Quarterly Results

October 26th, 2020Ahmedabad(India)

Torrent Pharma announces Q2 FY21 results click here

Quarterly Results

July 30th, 2020Ahmedabad(India)

Torrent Pharma announces Q1 FY21 results click here

Revenue Q1 FY 20-21

August 30th, 2020Ahmedabad(India)

Torrent Pharma reports its Revenue Q1 FY 20-21 click here

Archives >>

Contact Us

Follow Us On

Torrent Pharmaceuticals Ltd.

CIN: L24230GJ1972PLC002126
Off. Ashram Road, Ahmedabad - 380009, Gujarat, India.
Phone No. : +91-79-26599000 | Fax No: +91-79-26582100